Quofenix / Quinsair - direct healthcare professional communication (DHPC)

Delafloxacin / levofloxacin

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Systemic and inhaled fluoroquinolones: risk of heart valve regurgitation/incompetence

Key facts

• Medicine name:
  • Quofenix
  • Quinsair
• Active substance:
  • Delafloxacin
  • levofloxacin
• Regulatory outcome:
  Variation
• DHPC type:
  Safety signal
• Human ATC codes:
  • J01MA23
  • J01MA12
• Dissemination date:
  29/10/2020
• Related medicines:
  • Ciprofloxacin
  • Levofloxacin
  • Lomefloxacin
  • Moxifloxacin
  • Norfloxacin
  • Ofloxacin
  • Pefloxacin
  • Prulifloxacin
  • Rufloxacin